178 related articles for article (PubMed ID: 19457668)
1. Oxidation of carbidopa by tyrosinase and its effect on murine melanoma.
Gasowska-Bajger B; Frackowiak-Wojtasek B; Koj S; Cichoń T; Smolarczyk R; Szala S; Wojtasek H
Bioorg Med Chem Lett; 2009 Jul; 19(13):3507-10. PubMed ID: 19457668
[TBL] [Abstract][Full Text] [Related]
2. Indirect oxidation of the antitumor agent procarbazine by tyrosinase--possible application in designing anti-melanoma prodrugs.
Gasowska-Bajger B; Wojtasek H
Bioorg Med Chem Lett; 2008 Jun; 18(11):3296-300. PubMed ID: 18457951
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and analysis of activity of a potential anti-melanoma prodrug with a hydrazine linker.
Frąckowiak-Wojtasek B; Gąsowska-Bajger B; Mazurek M; Raniszewska A; Logghe M; Smolarczyk R; Cichoń T; Szala S; Wojtasek H
Eur J Med Chem; 2014 Jan; 71():98-104. PubMed ID: 24287558
[TBL] [Abstract][Full Text] [Related]
4. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
Jergil B; Lindbladh C; Rorsman H; Rosengren E
Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines.
Monteiro AS; Almeida J; Cabral G; Severino P; Videira PA; Sousa A; Nunes R; Pereira JD; Francisco AP; Perry MJ; Mendes E
Eur J Med Chem; 2013; 70():1-9. PubMed ID: 24125877
[TBL] [Abstract][Full Text] [Related]
6. Tyrosinase autoactivation and the chemistry of ortho-quinone amines.
Land EJ; Ramsden CA; Riley PA
Acc Chem Res; 2003 May; 36(5):300-8. PubMed ID: 12755639
[TBL] [Abstract][Full Text] [Related]
7. Kinetic characterization of the oxidation of carbidopa and benserazide by tyrosinase and peroxidase.
Munoz-Munoz JL; Garcia-Molina F; Garcia-Molina M; Tudela J; García-Cánovas F; Rodriguez-Lopez JN
Biosci Biotechnol Biochem; 2009 Jun; 73(6):1308-13. PubMed ID: 19502746
[TBL] [Abstract][Full Text] [Related]
8. Production of 6-hydroxydopa by human tyrosinase.
Hansson C; Rorsman H; Rosengren E; Wittbjer A
Acta Derm Venereol; 1985; 65(2):154-7. PubMed ID: 2408419
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 5-S-glutathionyldopa.
Carstam R; Edner C; Hansson C; Lindbladh C; Rorsman H; Rosengren E
Acta Derm Venereol Suppl (Stockh); 1986; 126():1-12. PubMed ID: 3103358
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
Gili A; Thomas PD; Ota M; Jimbow K
Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
[TBL] [Abstract][Full Text] [Related]
11. The involvement of histidine at the active site of Harding-Passey mouse melanoma tyrosinase.
Martínez JH; Solano F; García-Borrón JC; Iborra JL; Lozano JA
Biochem Int; 1985 Nov; 11(5):729-38. PubMed ID: 3937527
[TBL] [Abstract][Full Text] [Related]
12. Tyrosinase activity in the medium of human melanoma cell cultures.
Jergil B; Lindbladh C; Rorsman H; Rosengren E
Acta Derm Venereol; 1983; 63(3):205-8. PubMed ID: 6192632
[TBL] [Abstract][Full Text] [Related]
13. N-Substituted 2-(2,6-dinitrophenylamino)propanamides: novel prodrugs that release a primary amine via nitroreduction and intramolecular cyclization.
Sykes BM; Atwell GJ; Hogg A; Wilson WR; O'Connor CJ; Denny WA
J Med Chem; 1999 Feb; 42(3):346-55. PubMed ID: 9986704
[TBL] [Abstract][Full Text] [Related]
14. N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
Yamazaki Y; Kawano Y; Yamanaka A; Maruyama S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4178-82. PubMed ID: 19524439
[TBL] [Abstract][Full Text] [Related]
15. Tyrosinase-catalyzed oxidation of 3,4-dihydroxyphenylglycine.
Sugumaran M; Tan S; Sun HL
Arch Biochem Biophys; 1996 May; 329(2):175-80. PubMed ID: 8638949
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and preliminary in vitro biological evaluation of 4-[(4-hydroxyphenyl)sulfanyl]but-3-en-2-one, a 4-mercaptophenol derivative designed as a novel bifunctional antimelanoma agent.
Ruzza P; Rosato A; Nassi A; Rondina M; Zorzin M; Rossi CR; Floreani M; Quintieri L
J Med Chem; 2009 Aug; 52(15):4973-6. PubMed ID: 19601648
[TBL] [Abstract][Full Text] [Related]
17. Modulating effects of a novel skin-lightening agent, alpha-lipoic acid derivative, on melanin production by the formation of DOPA conjugate products.
Tsuji-Naito K; Hatani T; Okada T; Tehara T
Bioorg Med Chem; 2007 Mar; 15(5):1967-75. PubMed ID: 17218103
[TBL] [Abstract][Full Text] [Related]
18. Effects of salicylic acid on mushroom tyrosinase and B16 melanoma cells.
Tamura S; Nitoda T; Kubo I
Z Naturforsch C J Biosci; 2007; 62(3-4):227-33. PubMed ID: 17542489
[TBL] [Abstract][Full Text] [Related]
19. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
20. Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.
Vad NM; Kandala PK; Srivastava SK; Moridani MY
Chem Biol Interact; 2010 Feb; 183(3):462-71. PubMed ID: 19944085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
